PER 2.04% 10.0¢ percheron therapeutics limited

Charmaine Gittleson Speaks on FDA Feedback

  1. 3,154 Posts.
    lightbulb Created with Sketch. 561
    so we can dose higher.
  2. 4,694 Posts.
    lightbulb Created with Sketch. 1089
    Nice to hear from Dr. G....a different voice, one smart cookie!

    - Dose higher
    - PUL2.0 accepted end point
    - 12 month study
    - Tox study can run in parallel to trial
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
0.002(2.04%)
Mkt cap ! $90.15M
Open High Low Value Volume
10.0¢ 10.5¢ 10.0¢ $50.98K 508.4K

Buyers (Bids)

No. Vol. Price($)
3 69109 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 249627 5
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.